Volunteer for NIAID-funded clinical studies related to shingles on ClinicalTrials.gov.
Shingles, also known as herpes zoster, is a disease that affects an estimated 1 million people in the United States each year.
Although it is most common in people over age 50, if you have had chickenpox, you are at risk for developing shingles. Shingles is also more common in people with weakened immune systems from HIV infection, chemotherapy or radiation treatment, transplant operations, and stress.
Experimental Shingles Vaccine Proves Effective in Nationwide Study—June 1, 2005
NIAID Launches Major Step in Trial of Experimental Shingles Vaccine—June 15, 1999
News from NIAID-Supported Institutions
Last Updated October 22, 2012